Skip to main content
. 2020 Dec 16;65(1):e01009-20. doi: 10.1128/AAC.01009-20

TABLE 2.

Safety parameters and laboratory abnormalities upon diagnosis of pneumoniae

Safety or laboratory parameter No. (%) of animals
Control (n = 6) Linezolid (n = 6) Telavancin (n = 6)
Skin rash 0 (0) 0 (0) 0 (0)
Bronchospasm 0 (0) 0 (0) 0 (0)
Diarrhea 0 (0) 0 (0) 0 (0)
Vomiting 0 (0) 0 (0) 0 (0)
Hb reductiona 1 (16.7) 0 (0) 0 (0)
Platelet count reductiona 2 (33.7) 3 (50.0) 1 (16.7)
ALT level > ULN 1 (16.7) 2 (33.7) 1 (16.7)
Alkaline phosphatase level > 2× ULN 1 (16.7) 1 (16.7) 0 (0)
Abnormal potassium levelb 1 (16.7) 1 (16.7) 0 (0)
Creatinine level increasec 0 (0) 4 (66.7) 1 (16.7)
Creatinine level of >1.5 mg/dl 1 (16.7) 4 (66.7) 0 (0)
Urinary output reductiond 2 (33.7) 2 (33.7) 0 (0)
Furosemide administration 3 (50.0) 4 (66.7) 0 (0)
a

At least a 30% reduction from the value at pneumonia diagnosis.

b

Potassium level of <3.5 or >5.5 meq/liter.

c

Serum creatinine level increase of ≥25% from that at pneumonia diagnosis.

d

Urinary output of ≤0.5 ml · h/kg.

e

Hb, hemoglobin; ALT, alanine aminotransferase; ULN, upper limit of normal.